Ticker ARTL – Artelo Biosciences – sales, description, marketcap – Tickerday.com

ARTL

Artelo Biosciences

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 5.17M; Volume: 4.53M; AvgVol 3m: 557.94K; Beta: –;

Cost estimate:

P/E: –; EPS: -1.35; EPS growth quarter/prev quarter: -63.80%;

EPS growth this year: -336.10%; EPS growth past 5 years: ;

EPS ttm: -1.35;

P/S: ; P/B: 01.09; P/Cashflow: 3.61; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -90.90%; ROE – return on equity: -103.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 7.10%; Insider Transactions:0.00%;

Institutional Ownership: 0.30%; Institutional Transactions: ;

Data update: 07/10/2020.